Efficacy and safety of SGLT2 inhibitors in individuals with type 1 diabetes under continuous subcutaneous insulin infusion: a real-world study
Authors
Vania Benido Silva
Department of Endocrinology, Diabetes and Metabolism, Centro Hospitalar Universitario do Porto, Porto, Portugal
Liliana Fonseca
Department of Endocrinology, Diabetes and Metabolism, Centro Hospitalar Universitario do Porto, Porto, Portugal
Diana Borges Duarte
Department of Endocrinology, Diabetes and Metabolism, Centro Hospitalar Universitario do Porto, Porto, Portugal
Francisca Marques Puga
Department of Endocrinology, Diabetes and Metabolism, Centro Hospitalar Universitario do Porto, Porto, Portugal
Guilherme Assuncao
Department of Endocrinology, Diabetes and Metabolism, Centro Hospitalar Universitario do Porto, Porto, Portugal
Susana Garrido
Department of Endocrinology, Diabetes and Metabolism, Centro Hospitalar Universitario do Porto, Porto, Portugal
Sofia Teixeira
Department of Endocrinology, Diabetes and Metabolism, Centro Hospitalar Universitario do Porto, Porto, Portugal
Joana Vilaverde
Department of Endocrinology, Diabetes and Metabolism, Centro Hospitalar Universitario do Porto, Porto, Portugal
Maria Helena Cardoso
Department of Endocrinology, Diabetes and Metabolism, Centro Hospitalar Universitario do Porto, Porto, Portugal
Language: English
Page range: 144 - 151
Published on: Aug 10, 2023
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
Related subjects:
© 2023 Vania Benido Silva, Liliana Fonseca, Diana Borges Duarte, Francisca Marques Puga, Guilherme Assuncao, Susana Garrido, Sofia Teixeira, Joana Vilaverde, Maria Helena Cardoso, published by Slovak Academy of Sciences, Institute of Experimental Endocrinology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.